The effects of imatinib mesylate on immune globulin and T cell subset in patients with chronic myelocytic leukemia.
- Author:
Rui-rui GUI
;
Yan-li ZHANG
;
Bai-jun FANG
- Publication Type:Journal Article
- MeSH:
Adult;
Aged;
Benzamides;
therapeutic use;
Case-Control Studies;
Female;
Humans;
Imatinib Mesylate;
Immunoglobulins;
metabolism;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive;
drug therapy;
immunology;
Male;
Middle Aged;
Piperazines;
therapeutic use;
Pyrimidines;
therapeutic use;
T-Lymphocyte Subsets
- From:
Chinese Journal of Hematology
2012;33(3):225-226
- CountryChina
- Language:Chinese
